Design, synthesis, and biological evaluation of hydrophobic-tagged poly (ADP-ribose) polymerase 1 (PARP1) degraders
- Bioorg Chem. 2026 Mar:170:109507. doi: 10.1016/j.bioorg.2026.109507.
- 1. School of Pharmacy, North China University of Science and Technology, Tangshan 063210, China.
- 2. Pharmaceutical Department, Handan Central Hospital, Handan 056001, China.
- 3. School of Public health, North China University of Science and Technology, Tangshan 063210, China.
- 4. North China University of Science and Technology Affiliated Hospital, TangShan 063000, China.
- 5. School of Pharmacy, North China University of Science and Technology, Tangshan 063210, China. Electronic address: [email protected].
- 6. School of Pharmacy, North China University of Science and Technology, Tangshan 063210, China. Electronic address: [email protected].
Given its critical role in mediating the DNA damage response and repair, Poly (ADP-ribose) polymerase-1 (PARP1) has been established as a significant therapeutic target for Cancer and a multitude of Other human diseases. In this study, a novel series of hydrophobic tagging (HyT) derivatives were developed through design, synthesis, and evaluation to induce the degradation of PARP1. Leading compound 11e demonstrated significant efficacy in the triple-negative breast Cancer cell line MDA-MB-231, potently degrading PARP1 in a concentration- and time-dependent manner, thereby effectively inhibiting Cancer cell proliferation and migration. Moreover, a degradation of PARP1 was induced by 11e in various BRCA1/2-proficient carcinoma-derived lines, with potency observed at low compound levels. In conclusion, compound 11e, a novel and highly effective PARP1 degrading agent, displays superior degradation capability and holds considerable promise for future clinical applications.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Ligands for E3 LigaseResearch Areas: Others
-